ELUTIA INC. - CLASS A
4.1600
25-نوفمبر-24 15:45:01
15 متأخرة بدقائق
الأسهم
+0.0400
+0.97%
نطاق اليوم
3.9915 - 4.2700
ISIN
N/A
المصدر
NASDAQ
-
Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial Envelope
20 مارس 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
15 مارس 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics to Present at the Cowen 43rd Annual Health Care Conference
27 فبراير 2023 07:15:00 بحسب Nasdaq GlobeNewswire
-
09 يناير 2023 07:15:00 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation
15 ديسمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock
01 ديسمبر 2022 08:04:00 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock
30 نوفمبر 2022 15:08:00 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics to Participate in Upcoming Investor Conferences
21 نوفمبر 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics Reports Strong Third Quarter 2022 Revenue
14 نوفمبر 2022 15:01:00 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022
07 نوفمبر 2022 15:05:01 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors
24 أكتوبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets
11 أكتوبر 2022 15:35:48 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer
26 أغسطس 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
17 أغسطس 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
11 أغسطس 2022 15:05:02 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics Announces $25 Million Loan Facility with SWK Holdings
10 أغسطس 2022 17:56:35 بحسب Nasdaq GlobeNewswire
-
09 أغسطس 2022 16:57:55 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics to Report Second Quarter 2022 Financial Results on August 11, 2022
28 يوليو 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO
21 يونيو 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
Aziyo Biologics Provides Business Update and Reports First Quarter 2022 Financial Results
09 مايو 2022 15:05:02 بحسب Nasdaq GlobeNewswire